Truist Financial Corp reduced its position in shares of Revvity Inc. (NYSE:RVTY – Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 56,740 shares of the company’s stock after selling 651 shares during the period. Truist Financial Corp’s holdings in Revvity were worth $5,488,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of RVTY. Wealth Enhancement Advisory Services LLC boosted its holdings in Revvity by 3.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock valued at $544,000 after acquiring an additional 187 shares during the period. Ritholtz Wealth Management acquired a new position in shares of Revvity during the 1st quarter worth about $210,000. Amalgamated Bank boosted its stake in Revvity by 1.0% during the 1st quarter. Amalgamated Bank now owns 23,777 shares of the company’s stock valued at $2,516,000 after purchasing an additional 227 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its holdings in Revvity by 11.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company’s stock valued at $1,417,000 after buying an additional 1,343 shares during the last quarter. Finally, Family Legacy Financial Solutions LLC acquired a new stake in Revvity in the 2nd quarter valued at approximately $5,351,000. Institutional investors own 86.65% of the company’s stock.
Wall Street Analysts Forecast Growth
RVTY has been the subject of a number of research analyst reports. Evercore ISI cut their price target on Revvity from $116.00 to $115.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Bank of America cut their target price on shares of Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Raymond James Financial reissued an “outperform” rating and issued a $115.00 price target (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Barclays dropped their price objective on shares of Revvity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, Stifel Nicolaus reduced their target price on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a research note on Tuesday, July 29th. Ten equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $118.57.
Revvity Stock Down 0.7%
Shares of RVTY opened at $93.38 on Tuesday. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The company has a 50-day moving average price of $88.05 and a two-hundred day moving average price of $93.20. The stock has a market cap of $10.84 billion, a price-to-earnings ratio of 39.57, a P/E/G ratio of 3.14 and a beta of 0.98. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $129.50.
Revvity (NYSE:RVTY – Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The company had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same period in the prior year, the company posted $1.22 EPS. The company’s revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Equities analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.
Revvity Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity’s dividend payout ratio is currently 11.86%.
Revvity Company Profile
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Recommended Stories
- Five stocks we like better than Revvity
- What is a penny stock? A comprehensive guide
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- How to Buy Gold Stock and Invest in Gold
- 3 Exceptional Stocks to Build Long-Term Wealth
- What is a support level?
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.